{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:28:19Z","timestamp":1790080099470,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":599,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.rmed.2011.07.002","type":"journal-article","created":{"date-parts":[[2011,8,2]],"date-time":"2011-08-02T02:19:06Z","timestamp":1312251546000},"page":"1853-1860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD"],"prefix":"10.1016","volume":"105","author":[{"given":"Jeroen J.W.","family":"Liesker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Bathoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirkje S.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Timens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huib A.M.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2011.07.002_bib1","unstructured":"Rodriguez-Roisin R, Anzueto A, Bourbeau P, Calverley P, deQuia TS, Fukuchi Y et\u00a0al. Global initiative for chronic obstructive lung disease. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2009. Available from: www.goldcopd.com [updated 2009]."},{"key":"10.1016\/j.rmed.2011.07.002_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002991.pub2","article-title":"Inhaled corticosteroids for stable chronic obstructive pulmonary disease","author":"Yang","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rmed.2011.07.002_bib3","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (bronchitis randomized on NAC cost-utility study, BRONCUS): a randomised placebo-controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2011.07.002_bib4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.200206-512OC","article-title":"Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study","volume":"166","author":"van der Valk","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib5","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/thx.2004.034280","article-title":"Withdrawal of fluticasone propionate from combined salmeterol\/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial","volume":"60","author":"Wouters","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2011.07.002_bib6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1183\/09031936.00146306","article-title":"Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial","volume":"29","author":"Siva","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2011.07.002_bib7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/15412550802363360","article-title":"Anti-inflammatory effects of combined budesonide\/formoterol in COPD exacerbations","volume":"5","author":"Bathoorn","year":"2008","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2011.07.002_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(98)11326-0","article-title":"Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial","volume":"354","author":"Davies","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2011.07.002_bib9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2011.07.002_bib10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1378\/chest.06-2216","article-title":"Safety of sputum induction during exacerbations of COPD","volume":"131","author":"Bathoorn","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2011.07.002_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/thx.42.10.773","article-title":"A measure of quality of life for clinical trials in chronic lung disease","volume":"42","author":"Guyatt","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2011.07.002_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7525-1-13","article-title":"Development, validity and responsiveness of the clinical COPD questionnaire","volume":"1","author":"van der Molen","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.rmed.2011.07.002_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pcrj.2003.11.005","article-title":"Probability and determinants of relapse after discontinuation of inhaled corticosteroids in patients with COPD treated in general practice","volume":"13","author":"Schermer","year":"2004","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.rmed.2011.07.002_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.06-1316","article-title":"Risk indexes for exacerbations and hospitalizations due to COPD","volume":"131","author":"Niewoehner","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2011.07.002_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1183\/09031936.05.00078504","article-title":"Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression","volume":"26","author":"Gudmundsson","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2011.07.002_bib16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm.164.6.2006012","article-title":"Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study","volume":"164","author":"Garcia-Aymerich","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/thorax.57.2.137","article-title":"Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease","volume":"57","author":"Roberts","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2011.07.002_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/ajrccm.159.1.9803117","article-title":"Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease","volume":"159","author":"Kessler","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-130-5-199903020-00003","article-title":"Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease","volume":"130","author":"Nichol","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/thorax.58.2.100","article-title":"Risk factors of readmission to hospital for a COPD exacerbation: a prospective study","volume":"58","author":"Garcia-Aymerich","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2011.07.002_bib21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1378\/chest.07-1342","article-title":"Increased systemic inflammation is a risk factor for COPD exacerbations","volume":"133","author":"Groenewegen","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2011.07.002_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MAJ.0b013e3181bb8111","article-title":"BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease","volume":"339","author":"Faganello","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rmed.2011.07.002_bib23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1378\/chest.09-2459","article-title":"Self-rated health predicts acute exacerbations and hospitalizations in patients with COPD","volume":"138","author":"Farkas","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2011.07.002_bib24","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.rmed.2008.02.010","article-title":"Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease","volume":"102","author":"Bhatt","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib25","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib26","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.rmed.2009.12.007","article-title":"Determinants of poor 6-min walking distance in patients with COPD: the ECLIPSE cohort","volume":"104","author":"Spruit","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-0030-1254067","article-title":"The potential value of biomarkers in diagnosis and staging of COPD and exacerbations","volume":"31","author":"Patel","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib28","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1164\/ajrccm.150.6.7952628","article-title":"Airway eosinophilia in chronic bronchitis during exacerbations","volume":"150","author":"Saetta","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1183\/09031936.05.00047504","article-title":"Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease","volume":"25","author":"Fujimoto","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2011.07.002_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1465-9921-6-151","article-title":"MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbation","volume":"6","author":"Mercer","year":"2005","journal-title":"Respir Res"},{"key":"10.1016\/j.rmed.2011.07.002_bib31","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1164\/rccm.200506-859OC","article-title":"Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations","volume":"173","author":"Papi","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1378\/chest.115.3.697","article-title":"Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema","volume":"115","author":"Fujimoto","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2011.07.002_bib33","first-page":"17","article-title":"Eotaxin and CCR3 are up-regulated in exacerbations of chronic bronchitis","volume":"57","author":"Bocchino","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2011.07.002_bib34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/thx.2004.032516","article-title":"Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease","volume":"60","author":"Brightling","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2011.07.002_bib35","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/thx.50.4.360","article-title":"Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid","volume":"50","author":"Riise","year":"1995","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2011.07.002_bib36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1136\/thorax.58.8.680","article-title":"Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis","volume":"58","author":"White","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2011.07.002_bib37","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1164\/rccm.200404-543OC","article-title":"Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease","volume":"170","author":"Sin","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2011.07.002_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1513\/pats.200406-034MS","article-title":"Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease","volume":"2","author":"Man","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.rmed.2011.07.002_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1183\/09031936.03.00013303","article-title":"Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations","volume":"21","author":"Jones","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2011.07.002_bib40","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1513\/pats.200706-064TH","article-title":"The similarities and differences of epidemic cycles of chronic obstructive pulmonary disease and asthma exacerbations","volume":"4","author":"Johnston","year":"2007","journal-title":"Proc Am Thorac Soc"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611111002162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611111002162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:12:49Z","timestamp":1760613169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611111002162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0954611111002162"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2011.07.002","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2011.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}